Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy

Publication Date: May 13, 2019
Last Updated: December 15, 2022

Diagnosis

Who to Study

For individuals and decedents with either a clinical or necropsy diagnosis of ACM, genetic testing of the established ACM-susceptibility genes is recommended. (I, C-EO)
573

Treatment

Limitations of genetic testing 

The interpretation of a cardiac genetic test by a team of providers with expertise in genetics and cardiology can be useful. (IIa, C-EO)
573

Overview

Title

Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy

Authoring Organization